Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
08/22/1996 | CA2211975A1 Transcription factor - e2f-5 |
08/22/1996 | CA2211162A1 Nucleic acid-containing composition, preparation and use thereof |
08/22/1996 | CA2209227A1 New chemokines expressed in pancreas |
08/21/1996 | EP0727486A2 Tumour suppressor gene |
08/21/1996 | EP0727484A1 Process for growing virus |
08/21/1996 | EP0727483A2 Retrovirus of the HIV-group and its application |
08/21/1996 | EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use |
08/21/1996 | EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use |
08/21/1996 | EP0726957A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
08/21/1996 | EP0726955A1 Chimeric proteins comprising borrelia polypeptides: uses therefor |
08/21/1996 | EP0726952A1 Receptor on the surface of activated t-cells:acts-4 |
08/21/1996 | EP0726950A1 Helminth parasite antigen with aminopeptidase-like activity |
08/21/1996 | EP0726949A1 Opioid receptor: compositions and methods |
08/21/1996 | EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use |
08/21/1996 | EP0726913A1 Cytokines from natural killer or t cells |
08/21/1996 | EP0726908A1 Oncoprotein protein kinase |
08/21/1996 | EP0726777A1 Prokaryotic expression of mhc proteins |
08/21/1996 | EP0726776A1 Inhibition of hiv mucosal infection |
08/21/1996 | EP0726775A1 Vaccine and method for treatment of chlamydial infections |
08/21/1996 | EP0726774A1 Vaccine design and production |
08/21/1996 | EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation |
08/21/1996 | EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
08/21/1996 | EP0593440B1 Use of honey as vaccine |
08/21/1996 | EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells |
08/21/1996 | EP0500844B1 Drug containing cd14 |
08/21/1996 | CN1129460A Epstein-barr virus dna sequences encoding diagnostically relevant virus capid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic |
08/21/1996 | CN1129139A Use of azoles as virucidal agents in solutions of biologically active proteins |
08/20/1996 | US5547940 Using a polypeptide |
08/20/1996 | US5547932 Transfection |
08/20/1996 | US5547853 CD2-binding domain of lymphocyte function associated antigen 3 |
08/20/1996 | US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16 |
08/20/1996 | US5547834 Recombinant CMV neutralizing proteins |
08/20/1996 | US5547670 Polypeptides |
08/20/1996 | US5547667 Linker for bioactive agents |
08/20/1996 | US5547664 Expression of recombinant proteins in attenuated bacteria |
08/15/1996 | WO1996024844A1 Method of diagnosing immune diseases |
08/15/1996 | WO1996024675A1 GnRH-LEUKOTOXIN CHIMERAS |
08/15/1996 | WO1996024673A1 Mucosal vascular addressins and uses thereof |
08/15/1996 | WO1996024672A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6 |
08/15/1996 | WO1996024668A1 Human chemokine beta-11 and human chemokine alpha-1 |
08/15/1996 | WO1996024663A1 Herpes simplex virus mutants |
08/15/1996 | WO1996024662A1 Process to 'in vitro' propagate the hepatitis c virus (hcv) in non lymphoblastoid animal cell cultures and products thereof |
08/15/1996 | WO1996024357A1 Novel glucocorticoid response elements |
08/15/1996 | WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
08/15/1996 | CA2212706A1 Herpes simplex virus mutants |
08/15/1996 | CA2212573A1 Nucleotide and deduced amino acid sequences of tumor gene int6 |
08/15/1996 | CA2212379A1 Novel glucocorticoid response elements |
08/15/1996 | CA2212054A1 Gnrh-leukotoxin chimeras |
08/14/1996 | EP0726324A2 Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction |
08/14/1996 | EP0726315A1 Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
08/14/1996 | EP0726276A1 PEPTIDE CONTAINING AMINO ACID SEQUENCE OF FIMBRIAL PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) AND USE THEREOF |
08/14/1996 | EP0726275A1 Benzodiazepine protein conjugates and their use in benzodiazepine immunoassays |
08/14/1996 | EP0725838A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
08/14/1996 | EP0725831A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
08/14/1996 | EP0725828A1 Methods relating to ir-95 |
08/14/1996 | EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
08/14/1996 | EP0725824A1 Immunodominant human t-cell epitopes of hepatitis c virus |
08/14/1996 | EP0725823A1 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
08/14/1996 | EP0725798A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
08/14/1996 | EP0725796A1 Growth differentiation factor-10 |
08/14/1996 | EP0725792A1 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE |
08/14/1996 | EP0725789A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
08/14/1996 | EP0725655A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
08/14/1996 | EP0725654A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
08/14/1996 | EP0725653A1 Vaccine compositions |
08/14/1996 | EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof |
08/14/1996 | EP0575317B1 Recombinant anticoccidial vaccine |
08/14/1996 | EP0527762B1 Inhibition of allograft and concordant xenograft rejection |
08/14/1996 | EP0457804B1 M-csf monoclonal antibodies that recognize a neutralizing conformational epitope |
08/14/1996 | EP0396559B1 Hiv peptides, artificial hiv antigens and immunoassay kits |
08/14/1996 | EP0324774B1 Recombinant plasmid comprising a fragment of a dna segment coding for a 47 kda surface immunogen of treponema pallidum |
08/14/1996 | CN1129013A New growth-differentiation factor of the TGF-beta family |
08/14/1996 | CN1128954A Phosphazene polyelectrolytes as immunoadjuvants |
08/14/1996 | CN1128953A Hydrogel microencapsulated vaccines |
08/14/1996 | CN1128627A Prepn. of immunity food by immunity method, and method thereof |
08/13/1996 | US5545807 Production of antibodies from transgenic animals |
08/13/1996 | US5545726 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits |
08/13/1996 | US5545718 Synthetic peptides of the conjugate of ubiquitine and H2A histone |
08/13/1996 | US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor |
08/13/1996 | US5545553 Genetic engineering |
08/13/1996 | US5545550 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore |
08/13/1996 | US5545534 Contacting body fluid sample with diagnostic agent comprising mammalian bone sialoprotein, detecting amount of antibody which binds to the agent |
08/13/1996 | US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging |
08/13/1996 | US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell |
08/13/1996 | US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody |
08/13/1996 | US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody |
08/13/1996 | CA1338518C Antibody heteroconjugates for the killing of hiv-infected cells |
08/08/1996 | WO1996023886A1 Polypeptide fragments capable of competition with streptococcus mutans antigen i/ii |
08/08/1996 | WO1996023885A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
08/08/1996 | WO1996023882A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF |
08/08/1996 | WO1996023870A1 A method of preparing an undifferentiated cell |
08/08/1996 | WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
08/08/1996 | DE19521046C1 DNA encoding DNase and related vectors, host cells and antibodies |
08/08/1996 | CA2211993A1 Identification of dec, (dentritic and epithelial cells, 205 kda), a receptor with c-type lectin domains, nucleic acids encoding dec, and uses thereof |
08/08/1996 | CA2210928A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
08/08/1996 | CA2168712A1 Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction |
08/07/1996 | EP0724651A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
08/07/1996 | EP0724642A1 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
08/07/1996 | EP0724635A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis |
08/07/1996 | EP0724632A1 Stem cell proliferation factor |